The Middle EAST Alpha Mannosidosis Market was valued at USD 0.15 billion in 2024 and is projected to reach USD 0.45 billion by 2034, registering a CAGR of 11.5%. This growth trajectory is underpinned by increasing awareness and diagnosis of rare genetic disorders, coupled with advancements in treatment options. The rising prevalence of Alpha Mannosidosis, a rare lysosomal storage disorder, is...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek